Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Mortality Risk

Time to effect

Median: 4.3 weeks · IQR 4.3 weeks–4.3 weeks · Range 4.3 weeks–4.3 weeks — Reported in 1 of 2 studies

2 of 2 papers

Lactobacillus rhamnosus GG as a probiotic for preterm infants: a strain specific systematic review and meta-analysis.
- 2024-07-26
- Meta-Analysis · n = 1,037
- European journal of clinical nutrition 78(10)
- - Anitha Ananthan
  - Haribalakrishna Balasubramanian
  - Chandra Rath
  - Saravanan Muthusamy
  - Shripada Rao
  - Sanjay Patole
- PubMed: 39060543
- DOI: 10.1038/s41430-024-01474-0
5 Insights on
- Reduced Mortality Risk
- High evidence
- Rigorous Journal
- Clinical
mortality [3 RCTs, n = 207, RR: 0.99 (95% CI: 0.42, 2.33), P = 0.99]
Effect
Neutral
Effect size
Small
Significant
No
Effects of Lactobacillus rhamnosus GG on early postoperative outcome after pylorus-preserving pancreatoduodenectomy: a randomized trial.
- 2021-01-01
- RCT · n = 20
- European review for medical and pharmacological sciences 25(1)
- - M Folwarski
  - M Dobosz
  - S Małgorzewicz
  - K Skonieczna-Żydecka
  - K Kaźmierczak-Siedlecka
- PubMed: 33506929
- DOI: 10.26355/eurrev_202101_24407
7 Insights on
- Reduced Mortality Risk
- High evidence
- Clinical
There were no significant differences in mortality and infectious complications between groups.
Effect
Neutral
Effect size
Small
Significant
No